Q4 2023 Revenue Sees Significant Growth and Pipeline Progress
In the fourth quarter of 2023, the revenue for the company experienced a notable increase of 28%. This growth was primarily driven by the success of the New Products(i) category, which saw its revenue rise from $2.19 billion to $2.49 billion. The impressive performance of products such as Mounjaro and Zepbound contributed to this growth….